PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 21, 2021Expert Opinion on Therapeutic Patents127 citationsOpen Access

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19

View Full Paper
IVIlaria VicentiMZMaurizio ZazziFSFrancesco Saladini

Structured PICO

I
Intervention
Targeting SARS-CoV-2 RNA-dependent RNA polymerase

Targeting SARS-CoV-2 RNA-dependent RNA polymerase may provide useful information for drug development or repurposing against COVID-19.

Abstract

can provide useful information for drug development or drug repurposing to combat SARS-CoV-2 as well as future pandemics.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Vicenti et al. (2021) studied this question.

synapsesocial.com/papers/69fd339cea4a61241c5d1312https://doi.org/10.1080/13543776.2021.1880568
Ask AI
Helpful
Bookmark
Share
View Full Paper